These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2016988)

  • 21. Enhanced sensitivity to the behavioral effects of cocaine after chronic administration of D2-selective dopamine antagonists in the squirrel monkey.
    Howell LL; Byrd LD
    J Pharmacol Exp Ther; 1992 Sep; 262(3):907-15. PubMed ID: 1388204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioral differentiation of the stimulus properties of a dopaminergic D1 agonist from a D2 agonist.
    Cory-Slechta DA; Widzowski DV; Newland MC
    J Pharmacol Exp Ther; 1989 Sep; 250(3):800-8. PubMed ID: 2789282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissociation of cocaine-antagonist properties and motoric effects of the D1 receptor partial agonists SKF 83959 and SKF 77434.
    Platt DM; Rowlett JK; Spealman RD
    J Pharmacol Exp Ther; 2000 Jun; 293(3):1017-26. PubMed ID: 10869406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine D2 receptor mediation of the discriminative stimulus properties of LY 171555 (quinpirole).
    Weathersby RT; Appel JB
    Eur J Pharmacol; 1986 Dec; 132(1):87-91. PubMed ID: 2949989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discriminative stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes.
    Spealman RD; Bergman J; Madras BK; Melia KF
    J Pharmacol Exp Ther; 1991 Sep; 258(3):945-53. PubMed ID: 1679852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alteration of cataleptic responses induced by dopamine receptor antagonists after chronic cocaine administration in mice.
    Ushijima I; Mizuki Y; Yamada M
    Eur J Pharmacol; 1995 Oct; 285(1):55-9. PubMed ID: 8846811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium channel blockers antagonize some of cocaine's cardiovascular effects, but fail to alter cocaine's behavioral effects.
    Schindler CW; Tella SR; Prada J; Goldberg SR
    J Pharmacol Exp Ther; 1995 Feb; 272(2):791-8. PubMed ID: 7853196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
    Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cocaine-induced behavioral sensitization: effects of haloperidol and SCH 23390 treatments.
    Mattingly BA; Rowlett JK; Ellison T; Rase K
    Pharmacol Biochem Behav; 1996 Mar; 53(3):481-6. PubMed ID: 8866944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discriminatory roles for D1 and D2 dopamine receptor subtypes in the in vivo control of neostriatal cyclic GMP.
    Altar CA; Boyar WC; Kim HS
    Eur J Pharmacol; 1990 May; 181(1-2):17-21. PubMed ID: 1974856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excitatory neuronal responses to dopamine in the cerebral cortex: involvement of D2 but not D1 dopamine receptors.
    Bradshaw CM; Sheridan RD; Szabadi E
    Br J Pharmacol; 1985 Oct; 86(2):483-90. PubMed ID: 2932196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic haloperidol alters dopamine receptors: effects of cocaine exposure during the preweaning period.
    Shi X; Yin R; Dow-Edwards D
    Eur J Pharmacol; 1999 Apr; 370(3):241-9. PubMed ID: 10334498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute deleterious effects of cocaine on cardiac conduction, hemodynamics, and ventricular fibrillation threshold: effects of interaction with a selective dopamine D1 antagonist SCH 39166.
    Kanani PM; Guse PA; Smith WM; Barnett A; Ellinwood EH
    J Cardiovasc Pharmacol; 1998 Jul; 32(1):42-8. PubMed ID: 9676719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological and behavioral effects of D1 dopamine antagonists.
    Barnett A; Iorio LC; McQuade R; Chipkin RE
    Adv Exp Med Biol; 1988; 235():137-44. PubMed ID: 2976247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.
    Rowlett JK; Platt DM; Yao WD; Spealman RD
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1135-43. PubMed ID: 17351103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of a D1 and a D2 dopamine antagonist on the self-administration of cocaine and piribedil by rhesus monkeys.
    Woolverton WL
    Pharmacol Biochem Behav; 1986 Mar; 24(3):531-5. PubMed ID: 2871561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B; Katz JL; Alling K; Acri JB; Witkin JM
    J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antagonism of the discriminative stimulus effects of cocaine at two training doses by dopamine D2-like receptor antagonists.
    Costanza RM; Barber DJ; Terry P
    Psychopharmacology (Berl); 2001 Nov; 158(2):146-53. PubMed ID: 11702088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of cocaine- and food-maintained behavior by the D2-like receptor partial agonist terguride in squirrel monkeys.
    Platt DM; Rodefer JS; Rowlett JK; Spealman RD
    Psychopharmacology (Berl); 2003 Mar; 166(3):298-305. PubMed ID: 12589523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.